(Q42936504)

English

Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis

scientific article published on January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Elizabeth Robinson

4

object named as

Elizabeth Robinson

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

2

object named as

Amanda Wheeler

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

author name string

Christopher Carswell

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Jane Vanderpyl

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

777-787

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Health resource utilization associated with switching to risperidone long-acting injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The burden of schizophrenia on caregivers: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic use in Australia: the patients' perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Good tolerability equals good results: the patient's perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economics and schizophrenia: the real cost.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The applicability and generalizability of findings from clinical trials for health-policy decisions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cost-effectiveness analysis to illustrate the impact of cost definitions on results, interpretations and comparability of pharmacoeconomic studies in the US.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20712387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11537680-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42936504&oldid=2040311965"